nodes	percent_of_prediction	percent_of_DWPC	metapath
Minaprine—MAOA—Parkinson's disease	0.223	0.286	CbGaD
Minaprine—DRD1—Parkinson's disease	0.203	0.26	CbGaD
Minaprine—DRD2—Parkinson's disease	0.143	0.183	CbGaD
Minaprine—HTR2A—Parkinson's disease	0.111	0.142	CbGaD
Minaprine—CYP2D6—Parkinson's disease	0.101	0.13	CbGaD
Minaprine—MAOA—locus ceruleus—Parkinson's disease	0.00469	0.0579	CbGeAlD
Minaprine—HTR2A—enteric nervous system—Parkinson's disease	0.00464	0.0572	CbGeAlD
Minaprine—DRD1—telencephalic ventricle—Parkinson's disease	0.00372	0.046	CbGeAlD
Minaprine—HTR2A—myenteric nerve plexus—Parkinson's disease	0.00351	0.0433	CbGeAlD
Minaprine—HTR2A—locus ceruleus—Parkinson's disease	0.00306	0.0378	CbGeAlD
Minaprine—HTR2C—telencephalic ventricle—Parkinson's disease	0.00289	0.0357	CbGeAlD
Minaprine—HTR2A—cerebellar cortex—Parkinson's disease	0.00249	0.0308	CbGeAlD
Minaprine—HTR2A—sympathetic nervous system—Parkinson's disease	0.00242	0.0299	CbGeAlD
Minaprine—DRD1—nerve—Parkinson's disease	0.00235	0.029	CbGeAlD
Minaprine—DRD2—telencephalic ventricle—Parkinson's disease	0.0022	0.0271	CbGeAlD
Minaprine—Moclobemide—MAOB—Parkinson's disease	0.00195	0.44	CrCbGaD
Minaprine—HTR2A—pons—Parkinson's disease	0.00176	0.0218	CbGeAlD
Minaprine—HTR2A—autonomic nervous system—Parkinson's disease	0.00163	0.0201	CbGeAlD
Minaprine—HTR2A—telencephalic ventricle—Parkinson's disease	0.00145	0.0179	CbGeAlD
Minaprine—MAOA—nerve—Parkinson's disease	0.0014	0.0173	CbGeAlD
Minaprine—DRD2—nerve—Parkinson's disease	0.00139	0.0171	CbGeAlD
Minaprine—Moclobemide—MAOA—Parkinson's disease	0.00137	0.308	CrCbGaD
Minaprine—SLC6A4—hindbrain—Parkinson's disease	0.00129	0.016	CbGeAlD
Minaprine—HTR2A—peripheral nervous system—Parkinson's disease	0.00117	0.0145	CbGeAlD
Minaprine—MAOA—hindbrain—Parkinson's disease	0.00105	0.013	CbGeAlD
Minaprine—DRD2—hindbrain—Parkinson's disease	0.00104	0.0128	CbGeAlD
Minaprine—DRD1—brainstem—Parkinson's disease	0.00101	0.0124	CbGeAlD
Minaprine—DRD1—forebrain—Parkinson's disease	0.000973	0.012	CbGeAlD
Minaprine—HTR2A—nerve—Parkinson's disease	0.000915	0.0113	CbGeAlD
Minaprine—HTR2C—brainstem—Parkinson's disease	0.000783	0.00966	CbGeAlD
Minaprine—ACHE—medulla oblongata—Parkinson's disease	0.000766	0.00945	CbGeAlD
Minaprine—HTR2C—forebrain—Parkinson's disease	0.000755	0.00932	CbGeAlD
Minaprine—SLC6A4—brainstem—Parkinson's disease	0.000742	0.00916	CbGeAlD
Minaprine—SLC6A4—forebrain—Parkinson's disease	0.000716	0.00884	CbGeAlD
Minaprine—CHRM1—forebrain—Parkinson's disease	0.000713	0.0088	CbGeAlD
Minaprine—HTR2B—forebrain—Parkinson's disease	0.00071	0.00876	CbGeAlD
Minaprine—ACHE—midbrain—Parkinson's disease	0.0007	0.00864	CbGeAlD
Minaprine—HTR2A—hindbrain—Parkinson's disease	0.000685	0.00845	CbGeAlD
Minaprine—ACHE—spinal cord—Parkinson's disease	0.000683	0.00843	CbGeAlD
Minaprine—MAOA—embryo—Parkinson's disease	0.000657	0.0081	CbGeAlD
Minaprine—DRD1—midbrain—Parkinson's disease	0.000642	0.00792	CbGeAlD
Minaprine—CYP2D6—hindbrain—Parkinson's disease	0.000624	0.0077	CbGeAlD
Minaprine—Moclobemide—CYP2D6—Parkinson's disease	0.000621	0.14	CrCbGaD
Minaprine—CHRM1—cardiovascular system—Parkinson's disease	0.000603	0.00744	CbGeAlD
Minaprine—MAOA—brainstem—Parkinson's disease	0.000602	0.00743	CbGeAlD
Minaprine—HTR2B—cardiovascular system—Parkinson's disease	0.0006	0.0074	CbGeAlD
Minaprine—DRD2—brainstem—Parkinson's disease	0.000595	0.00735	CbGeAlD
Minaprine—MAOA—forebrain—Parkinson's disease	0.000581	0.00717	CbGeAlD
Minaprine—DRD2—forebrain—Parkinson's disease	0.000575	0.00709	CbGeAlD
Minaprine—DRD1—head—Parkinson's disease	0.000557	0.00687	CbGeAlD
Minaprine—HTR2C—medulla oblongata—Parkinson's disease	0.000546	0.00673	CbGeAlD
Minaprine—ACHE—cerebellum—Parkinson's disease	0.000542	0.00668	CbGeAlD
Minaprine—DRD1—nervous system—Parkinson's disease	0.000528	0.00651	CbGeAlD
Minaprine—DRD1—central nervous system—Parkinson's disease	0.000508	0.00627	CbGeAlD
Minaprine—HTR2C—midbrain—Parkinson's disease	0.000499	0.00616	CbGeAlD
Minaprine—MAOA—cardiovascular system—Parkinson's disease	0.000491	0.00606	CbGeAlD
Minaprine—HTR2C—spinal cord—Parkinson's disease	0.000487	0.00601	CbGeAlD
Minaprine—SLC6A4—midbrain—Parkinson's disease	0.000473	0.00584	CbGeAlD
Minaprine—SLC6A4—spinal cord—Parkinson's disease	0.000461	0.00569	CbGeAlD
Minaprine—ACHE—brain—Parkinson's disease	0.00044	0.00543	CbGeAlD
Minaprine—HTR2C—head—Parkinson's disease	0.000433	0.00534	CbGeAlD
Minaprine—HTR2A—embryo—Parkinson's disease	0.000428	0.00529	CbGeAlD
Minaprine—MAOA—medulla oblongata—Parkinson's disease	0.00042	0.00518	CbGeAlD
Minaprine—HTR2C—nervous system—Parkinson's disease	0.00041	0.00506	CbGeAlD
Minaprine—SLC6A4—head—Parkinson's disease	0.00041	0.00506	CbGeAlD
Minaprine—CHRM1—head—Parkinson's disease	0.000409	0.00504	CbGeAlD
Minaprine—HTR2B—head—Parkinson's disease	0.000406	0.00501	CbGeAlD
Minaprine—DRD1—brain—Parkinson's disease	0.000404	0.00498	CbGeAlD
Minaprine—HTR2C—central nervous system—Parkinson's disease	0.000395	0.00487	CbGeAlD
Minaprine—HTR2A—brainstem—Parkinson's disease	0.000393	0.00485	CbGeAlD
Minaprine—SLC6A4—nervous system—Parkinson's disease	0.000389	0.0048	CbGeAlD
Minaprine—CHRM1—nervous system—Parkinson's disease	0.000387	0.00478	CbGeAlD
Minaprine—HTR2B—nervous system—Parkinson's disease	0.000385	0.00475	CbGeAlD
Minaprine—MAOA—midbrain—Parkinson's disease	0.000384	0.00473	CbGeAlD
Minaprine—DRD2—midbrain—Parkinson's disease	0.000379	0.00468	CbGeAlD
Minaprine—HTR2A—forebrain—Parkinson's disease	0.000379	0.00468	CbGeAlD
Minaprine—SLC6A4—central nervous system—Parkinson's disease	0.000374	0.00462	CbGeAlD
Minaprine—MAOA—spinal cord—Parkinson's disease	0.000374	0.00462	CbGeAlD
Minaprine—CHRM1—central nervous system—Parkinson's disease	0.000373	0.0046	CbGeAlD
Minaprine—HTR2B—central nervous system—Parkinson's disease	0.000371	0.00458	CbGeAlD
Minaprine—CYP2D6—brainstem—Parkinson's disease	0.000358	0.00441	CbGeAlD
Minaprine—CYP2D6—forebrain—Parkinson's disease	0.000345	0.00426	CbGeAlD
Minaprine—MAOA—head—Parkinson's disease	0.000333	0.0041	CbGeAlD
Minaprine—DRD2—head—Parkinson's disease	0.000329	0.00406	CbGeAlD
Minaprine—HTR2A—cardiovascular system—Parkinson's disease	0.00032	0.00395	CbGeAlD
Minaprine—MAOA—nervous system—Parkinson's disease	0.000315	0.00389	CbGeAlD
Minaprine—HTR2C—brain—Parkinson's disease	0.000313	0.00387	CbGeAlD
Minaprine—DRD2—nervous system—Parkinson's disease	0.000312	0.00385	CbGeAlD
Minaprine—MAOA—central nervous system—Parkinson's disease	0.000304	0.00375	CbGeAlD
Minaprine—DRD2—central nervous system—Parkinson's disease	0.0003	0.00371	CbGeAlD
Minaprine—SLC6A4—brain—Parkinson's disease	0.000297	0.00367	CbGeAlD
Minaprine—MAOA—cerebellum—Parkinson's disease	0.000297	0.00366	CbGeAlD
Minaprine—CHRM1—brain—Parkinson's disease	0.000296	0.00365	CbGeAlD
Minaprine—HTR2B—brain—Parkinson's disease	0.000294	0.00363	CbGeAlD
Minaprine—DRD2—cerebellum—Parkinson's disease	0.000294	0.00362	CbGeAlD
Minaprine—Gefitinib—CYP2D6—Parkinson's disease	0.000291	0.0654	CrCbGaD
Minaprine—HTR2A—medulla oblongata—Parkinson's disease	0.000274	0.00338	CbGeAlD
Minaprine—HTR2A—midbrain—Parkinson's disease	0.00025	0.00309	CbGeAlD
Minaprine—HTR2A—spinal cord—Parkinson's disease	0.000244	0.00301	CbGeAlD
Minaprine—MAOA—brain—Parkinson's disease	0.000241	0.00297	CbGeAlD
Minaprine—DRD2—brain—Parkinson's disease	0.000238	0.00294	CbGeAlD
Minaprine—HTR2A—head—Parkinson's disease	0.000217	0.00268	CbGeAlD
Minaprine—Gefitinib—ABCB1—Parkinson's disease	0.000208	0.0467	CrCbGaD
Minaprine—HTR2A—nervous system—Parkinson's disease	0.000206	0.00254	CbGeAlD
Minaprine—HTR2A—central nervous system—Parkinson's disease	0.000198	0.00244	CbGeAlD
Minaprine—CYP2D6—head—Parkinson's disease	0.000198	0.00244	CbGeAlD
Minaprine—HTR2A—cerebellum—Parkinson's disease	0.000194	0.00239	CbGeAlD
Minaprine—CYP2D6—nervous system—Parkinson's disease	0.000187	0.00231	CbGeAlD
Minaprine—CYP2D6—central nervous system—Parkinson's disease	0.00018	0.00223	CbGeAlD
Minaprine—CYP2D6—cerebellum—Parkinson's disease	0.000176	0.00218	CbGeAlD
Minaprine—HTR2A—brain—Parkinson's disease	0.000157	0.00194	CbGeAlD
Minaprine—CYP2D6—brain—Parkinson's disease	0.000143	0.00177	CbGeAlD
Minaprine—HTR2A—Signaling by GPCR—TAC1—Parkinson's disease	1.87e-05	0.00014	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—DRD1—Parkinson's disease	1.86e-05	0.00014	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—TAC1—Parkinson's disease	1.86e-05	0.000139	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—ADRBK1—Parkinson's disease	1.85e-05	0.000139	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—DRD2—Parkinson's disease	1.84e-05	0.000139	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—HTR7—Parkinson's disease	1.84e-05	0.000139	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—ADORA2A—Parkinson's disease	1.84e-05	0.000138	CbGpPWpGaD
Minaprine—ACHE—Metabolism—CTGF—Parkinson's disease	1.83e-05	0.000138	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—EDN1—Parkinson's disease	1.83e-05	0.000138	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—DRD1—Parkinson's disease	1.83e-05	0.000137	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—ADRBK1—Parkinson's disease	1.82e-05	0.000137	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—DRD1—Parkinson's disease	1.82e-05	0.000137	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PENK—Parkinson's disease	1.81e-05	0.000136	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—MAG—Parkinson's disease	1.81e-05	0.000136	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—ADRBK1—Parkinson's disease	1.81e-05	0.000136	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—DRD3—Parkinson's disease	1.8e-05	0.000135	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—HTR7—Parkinson's disease	1.79e-05	0.000135	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—FGF20—Parkinson's disease	1.79e-05	0.000134	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PENK—Parkinson's disease	1.78e-05	0.000134	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—MAG—Parkinson's disease	1.78e-05	0.000134	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—MAG—Parkinson's disease	1.77e-05	0.000133	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PENK—Parkinson's disease	1.77e-05	0.000133	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—DRD3—Parkinson's disease	1.77e-05	0.000133	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—GFAP—Parkinson's disease	1.77e-05	0.000133	CbGpPWpGaD
Minaprine—ACHE—Metabolism of proteins—INS—Parkinson's disease	1.77e-05	0.000133	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—DRD2—Parkinson's disease	1.76e-05	0.000132	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—HTR7—Parkinson's disease	1.76e-05	0.000132	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—HTR2A—Parkinson's disease	1.76e-05	0.000132	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—DRD3—Parkinson's disease	1.76e-05	0.000132	CbGpPWpGaD
Minaprine—MAOA—Metabolism—CYP2D6—Parkinson's disease	1.76e-05	0.000132	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—HTR7—Parkinson's disease	1.75e-05	0.000132	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—DRD2—Parkinson's disease	1.75e-05	0.000132	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—GRM5—Parkinson's disease	1.75e-05	0.000131	CbGpPWpGaD
Minaprine—HTR2A—SIDS Susceptibility Pathways—IL6—Parkinson's disease	1.74e-05	0.000131	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—ADORA2A—Parkinson's disease	1.74e-05	0.00013	CbGpPWpGaD
Minaprine—MAOA—Metabolism—CTGF—Parkinson's disease	1.73e-05	0.00013	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—EDN1—Parkinson's disease	1.73e-05	0.00013	CbGpPWpGaD
Minaprine—ACHE—Metabolism—CYP2E1—Parkinson's disease	1.71e-05	0.000128	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—INSR—Parkinson's disease	1.7e-05	0.000128	CbGpPWpGaD
Minaprine—ACHE—Metabolism—NQO1—Parkinson's disease	1.69e-05	0.000127	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—ADRBK1—Parkinson's disease	1.68e-05	0.000126	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—GBA—Parkinson's disease	1.67e-05	0.000125	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—DBH—Parkinson's disease	1.67e-05	0.000125	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—FBP1—Parkinson's disease	1.67e-05	0.000125	CbGpPWpGaD
Minaprine—ACHE—Metabolism—TH—Parkinson's disease	1.66e-05	0.000125	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—HTR2A—Parkinson's disease	1.66e-05	0.000125	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PDYN—Parkinson's disease	1.66e-05	0.000125	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—ADRBK1—Parkinson's disease	1.65e-05	0.000124	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—ADRBK1—Parkinson's disease	1.65e-05	0.000124	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PDYN—Parkinson's disease	1.63e-05	0.000123	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—HTR7—Parkinson's disease	1.63e-05	0.000122	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—EDN1—Parkinson's disease	1.63e-05	0.000122	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PDYN—Parkinson's disease	1.62e-05	0.000122	CbGpPWpGaD
Minaprine—MAOA—Metabolism—CYP2E1—Parkinson's disease	1.61e-05	0.000121	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—FGB—Parkinson's disease	1.61e-05	0.000121	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—DRD2—Parkinson's disease	1.6e-05	0.00012	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—HTR7—Parkinson's disease	1.6e-05	0.00012	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—INSR—Parkinson's disease	1.6e-05	0.00012	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—HTR2A—Parkinson's disease	1.6e-05	0.00012	CbGpPWpGaD
Minaprine—ACHE—Metabolism—CYCS—Parkinson's disease	1.6e-05	0.00012	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—HTR1A—Parkinson's disease	1.6e-05	0.00012	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—HTR7—Parkinson's disease	1.59e-05	0.00012	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—DRD2—Parkinson's disease	1.59e-05	0.00012	CbGpPWpGaD
Minaprine—MAOA—Metabolism—NQO1—Parkinson's disease	1.59e-05	0.00012	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—TAC1—Parkinson's disease	1.57e-05	0.000118	CbGpPWpGaD
Minaprine—MAOA—Metabolism—TH—Parkinson's disease	1.57e-05	0.000118	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—GFAP—Parkinson's disease	1.56e-05	0.000117	CbGpPWpGaD
Minaprine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	1.55e-05	0.000116	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—DRD1—Parkinson's disease	1.54e-05	0.000116	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—GRM5—Parkinson's disease	1.54e-05	0.000116	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—GFAP—Parkinson's disease	1.53e-05	0.000115	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—FGF20—Parkinson's disease	1.53e-05	0.000115	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—GFAP—Parkinson's disease	1.53e-05	0.000115	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—GRM5—Parkinson's disease	1.52e-05	0.000114	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—FGB—Parkinson's disease	1.51e-05	0.000114	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—HTR2A—Parkinson's disease	1.51e-05	0.000113	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—GRM5—Parkinson's disease	1.51e-05	0.000113	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—HTR1A—Parkinson's disease	1.51e-05	0.000113	CbGpPWpGaD
Minaprine—MAOA—Metabolism—CYCS—Parkinson's disease	1.51e-05	0.000113	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—DRD3—Parkinson's disease	1.49e-05	0.000112	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—ADORA2A—Parkinson's disease	1.48e-05	0.000112	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—TAC1—Parkinson's disease	1.48e-05	0.000111	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—EDN1—Parkinson's disease	1.48e-05	0.000111	CbGpPWpGaD
Minaprine—DRD2—Circadian rythm related genes—IL6—Parkinson's disease	1.44e-05	0.000108	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—EDN1—Parkinson's disease	1.44e-05	0.000108	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—HTR2A—Parkinson's disease	1.42e-05	0.000107	CbGpPWpGaD
Minaprine—ACHE—Metabolism—COMT—Parkinson's disease	1.42e-05	0.000106	CbGpPWpGaD
Minaprine—CHRM1—Circadian rythm related genes—IL6—Parkinson's disease	1.41e-05	0.000106	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—EDN1—Parkinson's disease	1.41e-05	0.000106	CbGpPWpGaD
Minaprine—ACHE—Metabolism—GSTP1—Parkinson's disease	1.41e-05	0.000106	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—DRD3—Parkinson's disease	1.41e-05	0.000106	CbGpPWpGaD
Minaprine—ACHE—Metabolism—MAOA—Parkinson's disease	1.41e-05	0.000106	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—EDN1—Parkinson's disease	1.4e-05	0.000106	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—ADRBK1—Parkinson's disease	1.39e-05	0.000105	CbGpPWpGaD
Minaprine—ACHE—Metabolism—HMOX1—Parkinson's disease	1.39e-05	0.000104	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—INSR—Parkinson's disease	1.37e-05	0.000103	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—FGF20—Parkinson's disease	1.35e-05	0.000101	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—HTR7—Parkinson's disease	1.35e-05	0.000101	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—DRD2—Parkinson's disease	1.35e-05	0.000101	CbGpPWpGaD
Minaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	1.35e-05	0.000101	CbGpPWpGaD
Minaprine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	1.34e-05	0.000101	CbGpPWpGaD
Minaprine—MAOA—Metabolism—COMT—Parkinson's disease	1.33e-05	0.0001	CbGpPWpGaD
Minaprine—ACHE—Metabolism—ABCB1—Parkinson's disease	1.33e-05	0.0001	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—FGF20—Parkinson's disease	1.33e-05	9.99e-05	CbGpPWpGaD
Minaprine—MAOA—Metabolism—GSTP1—Parkinson's disease	1.33e-05	9.97e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—FGF20—Parkinson's disease	1.32e-05	9.93e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—ADRBK1—Parkinson's disease	1.32e-05	9.88e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—ADORA2A—Parkinson's disease	1.31e-05	9.84e-05	CbGpPWpGaD
Minaprine—MAOA—Metabolism—HMOX1—Parkinson's disease	1.31e-05	9.83e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—EDN1—Parkinson's disease	1.3e-05	9.79e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—FGB—Parkinson's disease	1.3e-05	9.73e-05	CbGpPWpGaD
Minaprine—ACHE—Metabolism—GSTM1—Parkinson's disease	1.29e-05	9.72e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—HTR2A—Parkinson's disease	1.29e-05	9.7e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—ADORA2A—Parkinson's disease	1.29e-05	9.68e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—HTR1A—Parkinson's disease	1.29e-05	9.68e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—EDN1—Parkinson's disease	1.28e-05	9.63e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—ADORA2A—Parkinson's disease	1.28e-05	9.63e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—EDN1—Parkinson's disease	1.28e-05	9.58e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—HTR7—Parkinson's disease	1.27e-05	9.57e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—DRD2—Parkinson's disease	1.27e-05	9.57e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—TAC1—Parkinson's disease	1.27e-05	9.53e-05	CbGpPWpGaD
Minaprine—MAOA—Metabolism—ABCB1—Parkinson's disease	1.26e-05	9.44e-05	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—HTR2A—Parkinson's disease	1.26e-05	9.43e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—DRD1—Parkinson's disease	1.24e-05	9.35e-05	CbGpPWpGaD
Minaprine—ACHE—Metabolism—GPX1—Parkinson's disease	1.24e-05	9.31e-05	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—HTR2A—Parkinson's disease	1.23e-05	9.23e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—DDC—Parkinson's disease	1.22e-05	9.2e-05	CbGpPWpGaD
Minaprine—MAOA—Metabolism—GSTM1—Parkinson's disease	1.22e-05	9.16e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—INSR—Parkinson's disease	1.21e-05	9.08e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—DRD3—Parkinson's disease	1.21e-05	9.05e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—INSR—Parkinson's disease	1.19e-05	8.94e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—INSR—Parkinson's disease	1.18e-05	8.89e-05	CbGpPWpGaD
Minaprine—MAOA—Metabolism—GPX1—Parkinson's disease	1.17e-05	8.77e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—GSTA4—Parkinson's disease	1.16e-05	8.69e-05	CbGpPWpGaD
Minaprine—ACHE—Metabolism—MTHFR—Parkinson's disease	1.14e-05	8.59e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—FGB—Parkinson's disease	1.14e-05	8.58e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—HTR2A—Parkinson's disease	1.14e-05	8.56e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—HTR1A—Parkinson's disease	1.14e-05	8.54e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—IGF2—Parkinson's disease	1.13e-05	8.5e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—ADRBK1—Parkinson's disease	1.13e-05	8.45e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—FGB—Parkinson's disease	1.12e-05	8.45e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—TAC1—Parkinson's disease	1.12e-05	8.41e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—HTR1A—Parkinson's disease	1.12e-05	8.4e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—FGB—Parkinson's disease	1.12e-05	8.4e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—HTR2A—Parkinson's disease	1.12e-05	8.38e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—HTR1A—Parkinson's disease	1.11e-05	8.36e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—TAC1—Parkinson's disease	1.1e-05	8.28e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—DRD1—Parkinson's disease	1.1e-05	8.25e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—TAC1—Parkinson's disease	1.1e-05	8.23e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—IGF1R—Parkinson's disease	1.09e-05	8.22e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—HTR7—Parkinson's disease	1.09e-05	8.19e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—DRD2—Parkinson's disease	1.09e-05	8.19e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—EDN1—Parkinson's disease	1.08e-05	8.12e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—DRD1—Parkinson's disease	1.08e-05	8.12e-05	CbGpPWpGaD
Minaprine—MAOA—Metabolism—MTHFR—Parkinson's disease	1.08e-05	8.1e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—DRD1—Parkinson's disease	1.07e-05	8.07e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—IGF2—Parkinson's disease	1.07e-05	8.02e-05	CbGpPWpGaD
Minaprine—ACHE—Metabolism—APOE—Parkinson's disease	1.07e-05	8e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—DRD3—Parkinson's disease	1.06e-05	7.99e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—DRD3—Parkinson's disease	1.05e-05	7.86e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	1.04e-05	7.82e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—DRD3—Parkinson's disease	1.04e-05	7.82e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—IGF1R—Parkinson's disease	1.03e-05	7.75e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—MAOB—Parkinson's disease	1.03e-05	7.74e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—EDN1—Parkinson's disease	1.02e-05	7.66e-05	CbGpPWpGaD
Minaprine—MAOA—Metabolism—APOE—Parkinson's disease	1e-05	7.54e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—NGF—Parkinson's disease	9.94e-06	7.46e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—ADRBK1—Parkinson's disease	9.93e-06	7.46e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—ADRBK1—Parkinson's disease	9.77e-06	7.34e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—ADRBK1—Parkinson's disease	9.72e-06	7.3e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—HTR7—Parkinson's disease	9.62e-06	7.22e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—DRD2—Parkinson's disease	9.46e-06	7.11e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—HTR7—Parkinson's disease	9.46e-06	7.11e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—HTR2A—Parkinson's disease	9.46e-06	7.11e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—DRD2—Parkinson's disease	9.41e-06	7.07e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—HTR7—Parkinson's disease	9.41e-06	7.07e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—NGF—Parkinson's disease	9.37e-06	7.04e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—IGF2—Parkinson's disease	9.13e-06	6.86e-05	CbGpPWpGaD
Minaprine—ACHE—Metabolism—INS—Parkinson's disease	9.1e-06	6.83e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—HTR2A—Parkinson's disease	8.92e-06	6.7e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—IGF1R—Parkinson's disease	8.83e-06	6.63e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—APOE—Parkinson's disease	8.8e-06	6.61e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—EDN1—Parkinson's disease	8.72e-06	6.55e-05	CbGpPWpGaD
Minaprine—MAOA—Metabolism—INS—Parkinson's disease	8.57e-06	6.44e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—APOE—Parkinson's disease	8.29e-06	6.23e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—IGF2—Parkinson's disease	8.06e-06	6.05e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—NGF—Parkinson's disease	8.02e-06	6.02e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—IGF2—Parkinson's disease	7.93e-06	5.96e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—IGF2—Parkinson's disease	7.89e-06	5.92e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—IGF1R—Parkinson's disease	7.79e-06	5.85e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—EDN1—Parkinson's disease	7.7e-06	5.78e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—IGF1R—Parkinson's disease	7.67e-06	5.76e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—HTR2A—Parkinson's disease	7.63e-06	5.73e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—IGF1R—Parkinson's disease	7.63e-06	5.73e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—EDN1—Parkinson's disease	7.58e-06	5.69e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—EDN1—Parkinson's disease	7.54e-06	5.66e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—CTGF—Parkinson's disease	7.52e-06	5.65e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—INS—Parkinson's disease	7.51e-06	5.64e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—APOE—Parkinson's disease	7.1e-06	5.33e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—INS—Parkinson's disease	7.09e-06	5.32e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—NGF—Parkinson's disease	7.08e-06	5.31e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	7.01e-06	5.26e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—NGF—Parkinson's disease	6.96e-06	5.23e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—NQO1—Parkinson's disease	6.93e-06	5.2e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—NGF—Parkinson's disease	6.93e-06	5.2e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—TH—Parkinson's disease	6.83e-06	5.13e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—HTR2A—Parkinson's disease	6.74e-06	5.06e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—HTR2A—Parkinson's disease	6.59e-06	4.95e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—CYCS—Parkinson's disease	6.56e-06	4.92e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—APOE—Parkinson's disease	6.26e-06	4.7e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—APOE—Parkinson's disease	6.16e-06	4.63e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—APOE—Parkinson's disease	6.13e-06	4.6e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—INS—Parkinson's disease	6.06e-06	4.55e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—COMT—Parkinson's disease	5.81e-06	4.36e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—GSTP1—Parkinson's disease	5.78e-06	4.34e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—MAOA—Parkinson's disease	5.76e-06	4.33e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—HMOX1—Parkinson's disease	5.7e-06	4.28e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CASP3—Parkinson's disease	5.59e-06	4.2e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—IL6—Parkinson's disease	5.56e-06	4.17e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—ABCB1—Parkinson's disease	5.47e-06	4.11e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—INS—Parkinson's disease	5.35e-06	4.02e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—GSTM1—Parkinson's disease	5.31e-06	3.99e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CASP3—Parkinson's disease	5.28e-06	3.96e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—INS—Parkinson's disease	5.26e-06	3.95e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—IL6—Parkinson's disease	5.24e-06	3.94e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—INS—Parkinson's disease	5.24e-06	3.93e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—MAPK8—Parkinson's disease	5.14e-06	3.86e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—GPX1—Parkinson's disease	5.08e-06	3.82e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—MAPK8—Parkinson's disease	4.85e-06	3.64e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—MTHFR—Parkinson's disease	4.69e-06	3.52e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CASP3—Parkinson's disease	4.51e-06	3.39e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—IL6—Parkinson's disease	4.48e-06	3.37e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—APOE—Parkinson's disease	4.37e-06	3.28e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—MAPK8—Parkinson's disease	4.15e-06	3.12e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CASP3—Parkinson's disease	3.98e-06	2.99e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—IL6—Parkinson's disease	3.96e-06	2.97e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CASP3—Parkinson's disease	3.92e-06	2.94e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CASP3—Parkinson's disease	3.9e-06	2.93e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—IL6—Parkinson's disease	3.89e-06	2.92e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—IL6—Parkinson's disease	3.87e-06	2.91e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—INS—Parkinson's disease	3.73e-06	2.8e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—MAPK8—Parkinson's disease	3.66e-06	2.75e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—MAPK8—Parkinson's disease	3.6e-06	2.71e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—MAPK8—Parkinson's disease	3.58e-06	2.69e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—IL6—Parkinson's disease	3.28e-06	2.47e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—IL6—Parkinson's disease	3.1e-06	2.33e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—IL6—Parkinson's disease	2.65e-06	1.99e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—IL6—Parkinson's disease	2.34e-06	1.76e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—IL6—Parkinson's disease	2.3e-06	1.73e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—IL6—Parkinson's disease	2.29e-06	1.72e-05	CbGpPWpGaD
